Akron Children's Logo
Skip to main content
Close Tools Menu Icon

Operator:

330-543-1000

Questions or Referrals:
ASK CHILDREN‘S

Close Phone Menu Icon
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Incidence of and Risk Factors for Fibrosing Colonopathy in Patients With Cystic Fibrosis

Full IRB Study Title:
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors

IRB Study ID: 996785-2

For complete information, please view the study on clinicaltrials.gov

Lead Investigator

Gregory Omlor

Gregory Omlor, MD, FAAP

Director, Lewis H Walker CF Center; Pediatric Pulmonologist; Pediatric Sleep Medicine


Lewis H. Walker, MD, Cystic Fibrosis CenterRobert T. Stone, MD, Respiratory CenterPediatric Sleep Medicine

More about this provider

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.